SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas upcoming earnings report is the main focus, with traders weighing whether results can support its recent run after a sharp pullback. Some are positioning for a rebound, while others warn that the defensive-staples rally has left the shares overextended.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

RDDT is drawing attention ahead of its quarterly report, with traders focused on advertising and user growth and whether AI data-licensing deals can add momentum. Optimism about past earnings beats and ad trends is balanced by concerns over user metrics, a lack of new deal announcements, insider selling, and the stocks weak, choppy performance.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is drawing attention for volatile swings and extended consolidation after sharp meme-coin rallies and pullbacks, with traders watching for a resistance breakout. Bullish calls for another run compete with concerns about weak volume, fading pops and PEPE following broader crypto moves, especially Bitcoin.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is drawing attention amid volatile, uneven price action and debate over whether it can regain momentum relative to Bitcoin. Bulls point to a possible breakout and the upcoming CashVM upgrade, while skeptics question BCHs utility and expect further declines; no single catalyst is clearly driving the discussion.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Reported Phase 2 data for BioNTech and Bristol Myers Squibbs pumitamig-plus-docetaxel regimen in previously treated advanced lung cancer are drawing attention. Traders are weighing the response and progression-free-survival signal against questions about durability, while some remain unimpressed with the broader results and are watching for further pipeline catalysts.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodromes planned merger with Velodrome and expansion into a unified, multi-chain liquidity network are driving attention, with traders focused on potential new fee streams, broader reach, and buybacks. The community is bullish on the growth opportunity but debates whether token emissions and sell-the-news pressure could weigh on AERO.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins sharp pullback below a key psychological support level and reports of leveraged long liquidations dominate discussion, with traders debating whether the move is a temporary liquidity flush or the start of a deeper correction. Some view the dip as an accumulation opportunity, while bears point to weakening momentum and further downside risk.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is drawing attention after a breakout to record highs as crude prices strengthen, with traders also positioning around the companys upcoming earnings report. Sentiment is broadly bullish on the momentum, though some caution that elevated expectations and oil-price volatility could make the report a test for the rally.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs planned all-stock acquisition of cybersecurity firm Elisity, alongside a large equity raise, has put dilution and capital allocation at the center of the discussion. Traders are divided between concerns about shareholder dilution, deal cost and execution, and the view that Elisity expands IonQs quantum-security strategy.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is attracting attention after a sharp rally and volatile pullback, with traders focused on its privacy-coin narrative and claims of capital rotating into ZEC, alongside interest in Winklevoss- and Cypherpunk-linked accumulation and the upcoming NU7 upgrade. Bulls see the pullback as a buying opportunity and view Zcash as a privacy-focused alternative to Bitcoin, while bears argue the run may have been overextended and expect further losses.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novo Nordisk Holds Its 2026 Outlook As FDA Review Of Its Blood Disorder Drug Runs Long

Equity

The FDA has told Novo that its review of the biologics license application is still underway and has not given a new date for a decision.

NVO Stock On Track For Worst Week In Over 6 Months After Strategy Day — Direct US Listing Talks, Drug Approval Fail To Halt Slip

NVO stock is down 11% this week, on track for its worst week since late February if losses hold. 


NVO Stock Jumps 4% As European Committee Backs Novo’s Haemophilia Pen 

The Committee for Medicinal Products for Human Use recommended European Union marketing authorization for Frehemgo in adults and children with haemophilia A on Thursday.


AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss — Executive ‘Disappointed,’ Reiterates Breast Cancer Focus 

A combination of the company’s breast cancer drug Etcamah did not delay worsening of the disease enough to meet the SERENA-4 late-stage trial’s main goal, AstraZeneca said. 


Want to Tap Global Growth? These Equity ETFs Could Benefit

Seeking growth beyond U.S. borders? Global equity ETFs could offer diversification and exposure to attractive opportunities across international markets.

NVO Stock Drops 6% Despite Raised Guidance As Investors Worry About Injectable GLP-1 Sales Future

Novo now expects underlying sales and operating profit in the range of 0% to –6% for the year.

NVO Stock Ends Three-Month Winning Streak As Novo Nordisk’s Key Heart Drug Flops, Competition Goes To Court

The Danish drugmaker reported on Friday that its experimental cardiovascular drug ziltivekimab failed a key late-stage trial, marking a significant pipeline setback in its efforts to diversify beyond blockbuster obesity and diabetes treatments.


Global ETFs to Diversify as Tech Weakness Weighs on Markets

The AI trade is under pressure as a semiconductor slump and financing concerns rattle markets, making global ETFs worth a closer look.

NVO Stock Jumps 3% As EU Approves Oral Wegovy Pill — Retail Notes LLY Is ‘Clearly Behind’ Its Danish Counterpart

Oral Wegovy is now cleared in all EU member states.


Global ETFs Back in the Spotlight on Macroeconomic Tailwinds

Easing geopolitical tensions, a softer dollar and improving risk appetite are reviving interest in global equity ETFs.

American Century ETF Trust - Avantis International Equity ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Novo said the agency extended the review because remediation at the facility is still ongoing.</li><li>The company said the longer review does not change its 2026 financial outlook.</li><li>Novo’s rare blood-disorders sales were about DKK 12.0 billion in 2025, against group sales of DKK 309 billion.</li></ul><p>Danish drugmaker Novo Nordisk (NVO) said on Friday that U.S. approval of its haemophilia A drug denecimig will slip past the third quarter because fixes at a manufacturing site are still underway.&nbsp;</p><p>The FDA has told Novo that its review of the biologics license application is still underway and has not provided a new decision date. Novo filed the application in September 2025 for adults and children with haemophilia A, with or without inhibitors, and had expected a ruling in the third quarter of 2026.</p><h2 class="st-heading-2">A Plant Issue, Not A Clinical One, Says Novo</h2><p>The delay follows a pre-license inspection of the manufacturing site. Novo said the agency extended the review because remediation at the facility is still ongoing. The company said it is already addressing the requests and working with the FDA on the remaining items. It also said the inspection feedback does not affect other marketed Novo products, and that the agency has not flagged deficiencies in the clinical efficacy or safety data in the filing.</p><p>Novo said the longer review does not change its 2026 financial outlook. It now aims to launch denecimig in the United States in the first half of 2027, pending a decision.</p><p>Novo’s rare blood-disorders sales were about DKK 12.0 billion in 2025, against group sales of DKK 309 billion. Obesity care alone was DKK 82 billion. Outside analysts have put denecimig’s peak sales near $2 billion a year. Roche’s Hemlibra, the drug it would have to take share from, did about $5.8 billion last year.</p><h2 class="st-heading-2">What The Drug Is Meant To Do</h2><p>Denecimig is a bispecific antibody designed to mimic factor VIIIa, the clotting protein missing or defective in haemophilia A.&nbsp; Novo is seeking approval for prophylaxis — treatment meant to prevent bleeds — on a monthly, every-two-week, or weekly schedule, including in patients who have developed inhibitors to standard factor replacement.</p><p>The filing rests on the FRONTIER program. FRONTIER2 tested weekly and monthly dosing in adults and adolescents 12 and older. FRONTIER3 did the same in children under 12. FRONTIER4, an open-label extension, looked at every-two-week dosing and longer-term safety across all three schedules.&nbsp;</p><p>On Sept. 17, denecimig received a positive opinion from the European Medicines Agency’s human medicines committee and is now also awaiting a European Commission decision.</p><h2 class="st-heading-2">How Did NVO Retail Traders React?</h2><p>On Stocktwits, retail sentiment around <a class="mention" data-mention="$NVO" data-symbol-id="NVO" href="https://stocktwits.com/symbol/NVO" target="_blank">NVO stock</a> stayed neutral over the past 24 hours, while message volume remained low.&nbsp;</p><p>NVO stock has fallen 27% year-to-date.&nbsp;</p><p>Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/spcx-stock-climbs-as-three-thursday-launches-meet-start-of-google-s-920-million-ai-pact/cZDjn9cRBKN">SPCX Stock Climbs As Three Thursday Launches Meet Start Of Google’s $920 Million AI Pact</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. 

Novo Nordisk A/S

VanEck Pharmaceutical ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$88.74
Prev Close	$89.24
Open	$88.56
Dividend Yield	N/A
50-Day Moving Average	$91.84
Beta	N/A
Avg. Volume	1.2M
PE Ratio	N/A

52-Week High	$94.82
52-Week Low	$77.20
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

AVDE Fundamentals